Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response is a research paper published in Pathogens and Immunity (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: UM1 AI069424
NIAID NIH HHS
Grant: UM1 AI069494
NIAID NIH HHS
Grant: UM1 AI068634
NIAID NIH HHS
Grant: U01 AI068636
NIAID NIH HHS
Grant: UM1 AI069463
NIAID NIH HHS
Grant: UM1 AI069423
NIAID NIH HHS
Grant: UM1 AI068636
NIAID NIH HHS
Grant: U01 AI069463
NIAID NIH HHS
Grant: UM1 AI069412
National Institutes of Health
Grant: 3UM1AI068636-19SC
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
National Institutes of Health
Grant: 5UM1AI068634-09
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
National Institutes of Health
Grant: 3UM1AI106701-12S1
AIDS Clinical Trial Group Laboratory Center
FWCI
0.90
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals